Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Clinical trial NCT01105702 · TERMINATED
Trial details
- NCT number
- NCT01105702
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2014-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.